Shree Ganesh Bio-Tech
0.77
+0.02(+2.67%)
Market Cap₹30.70 Cr
PE Ratio75.00
IndustryHealthcare
Company Performance:
1D+2.67%
1M0.00%
6M-14.44%
1Y-27.36%
5Y-85.87%
View Company Insightsright
Latest news about Shree Ganesh Bio-Tech
Shree Ganesh Biotech Reports 37.5% Jump in Net Profit for Quarter Ended June Jul 25, 2025
Shree Ganesh Bio-Tech (India) Limited reported a net profit of Rs. 32.70 lacs for Q1, up 37.5% year-over-year, despite a 61.1% decline in revenue to Rs. 138.36 lacs. Total income fell 54.2% to Rs. 179.89 lacs, while expenses were reduced by 60.1% to Rs. 147.19 lacs. The company maintained its EPS at Rs. 0.01. The Board of Directors approved these unaudited financial results on July 25.